GoodRx Holdings, Inc. (GDRX) Net Cash Provided by (Used in) Financing Activities USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
GoodRx Holdings, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2020 to 2024.
  • GoodRx Holdings, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$161 M, a 1042% decline year-over-year.
  • GoodRx Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$167 M, a 39.2% decline from 2022.
  • GoodRx Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$120 M, a 294% decline from 2021.
  • GoodRx Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$30.5 M, a 103% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$161 M -$147 M -1042% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 -$14.1 M +$77.3 M +84.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 -$91.4 M -$77.4 M -552% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 -$14 M -$41.6 M -151% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $27.6 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.